基本信息
浏览量:184
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
His research focuses on molecularly-targeted therapeutics for acute leukemia. His principal expertise is in FLT3 inhibitors for AML and he has played a leading role in clinical trails of these agents. He also studies other agents targeting signal transduction, such as tyrosine kinase inhibitors for Ph-like ALL and inhibitors of oncogenic PI3K/AKT/mTOR signaling. His laboratory studies focus on phospho-specific flow cytometry of fixed, unfractionated blood and marrow as a method to quantify pharmacodynamic response to signal transduction inhibitors. He is additionally interested in preclinical drug screening in cellular and murine xenotransplantation models of acute leukemia.
研究兴趣
论文共 262 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Hematologistno. 3 (2024)
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 15 (2024): 1766-1775
Transplantation and Cellular Therapyno. 2 (2024): S407-S408
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2302474-JCO2302474, (2024)
Haematologicano. 8 (2024): 2732-2737
Transplantation and Cellular Therapyno. 2 (2024): S44-S45
Transplantation and cellular therapyno. 4 (2024): 415.e1-415.e16
Transplantation and cellular therapyno. 4 (2023): 265-274
HemaSphereno. S3 (2023): e61150fb-e61150fb
加载更多
作者统计
#Papers: 263
#Citation: 9374
H-Index: 40
G-Index: 94
Sociability: 7
Diversity: 2
Activity: 90
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn